GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Vision Biotechnology Co Ltd (ROCO:3218) » Definitions » Total Assets

Universal Vision Biotechnology Co (ROCO:3218) Total Assets : NT$5,131 Mil (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Universal Vision Biotechnology Co Total Assets?

Universal Vision Biotechnology Co's Total Assets for the quarter that ended in Dec. 2023 was NT$5,131 Mil.

During the past 12 months, Universal Vision Biotechnology Co's average Total Assets Growth Rate was 8.20% per year. During the past 3 years, the average Total Assets Growth Rate was 18.60% per year. During the past 5 years, the average Total Assets Growth Rate was 21.60% per year. During the past 10 years, the average Total Assets Growth Rate was 14.10% per year.

During the past 13 years, Universal Vision Biotechnology Co's highest 3-Year average Total Assets Growth Rate was 28.70%. The lowest was -1.50%. And the median was 14.10%.

Total Assets is connected with ROA %. Universal Vision Biotechnology Co's annualized ROA % for the quarter that ended in Dec. 2023 was 20.31%. Total Assets is also linked to Revenue through Asset Turnover. Universal Vision Biotechnology Co's Asset Turnover for the quarter that ended in Dec. 2023 was 0.20.


Universal Vision Biotechnology Co Total Assets Historical Data

The historical data trend for Universal Vision Biotechnology Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Vision Biotechnology Co Total Assets Chart

Universal Vision Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,647.18 3,169.14 3,749.65 4,505.78 5,130.58

Universal Vision Biotechnology Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,505.78 4,875.38 5,004.07 4,840.56 5,130.58

Universal Vision Biotechnology Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Universal Vision Biotechnology Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=3342.975+1787.609
=5,131

Universal Vision Biotechnology Co's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=3342.975+1787.609
=5,131

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Universal Vision Biotechnology Co  (ROCO:3218) Total Assets Explanation

Total Assets is connected with ROA %.

Universal Vision Biotechnology Co's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=1012.552/( (4840.562+5130.584)/ 2 )
=1012.552/4985.573
=20.31 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Universal Vision Biotechnology Co's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=992.876/( (4840.562+5130.584)/ 2 )
=992.876/4985.573
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Universal Vision Biotechnology Co Total Assets Related Terms

Thank you for viewing the detailed overview of Universal Vision Biotechnology Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Vision Biotechnology Co (ROCO:3218) Business Description

Traded in Other Exchanges
N/A
Address
No. 3-1, Yuanyuan Street, 4th Floor, Nangang District, Taipei, TWN, 115
Universal Vision Biotechnology Co Ltd provides eye treatment and related medical services in Taiwan. It also provides optical devices, glasses, lens and other vision aid products, optometric services, sales and leasing of medical devices, providing of hospital management and technical consultancy services.

Universal Vision Biotechnology Co (ROCO:3218) Headlines

No Headlines